I
Ian L. Sargent
Researcher at University of Oxford
Publications - 186
Citations - 25306
Ian L. Sargent is an academic researcher from University of Oxford. The author has contributed to research in topics: Syncytiotrophoblast & Placenta. The author has an hindex of 68, co-authored 186 publications receiving 23269 citations. Previous affiliations of Ian L. Sargent include Technische Universität München & John Radcliffe Hospital.
Papers
More filters
Journal ArticleDOI
Presence of fetal DNA in maternal plasma and serum
Y.M. Dennis Lo,Noemi Corbetta,Paul Chamberlain,Vik Rai,Ian L. Sargent,Christopher W.G. Redman,James S. Wainscoat +6 more
TL;DR: The finding of circulating fetal DNA in maternal plasma may have implications for non-invasive prenatal diagnosis, and for improving the understanding of the fetomaternal relationship.
Journal ArticleDOI
Latest advances in understanding preeclampsia.
TL;DR: Recent work on the causes of preeclampsia is summarized, which reveals a new mode of maternal immune recognition of the fetus, relevant to the condition, and circulating factors derived from the placenta are now better understood.
Journal ArticleDOI
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis
R Dragovic,Chris Gardiner,Alexandra S. Brooks,Dionne Tannetta,David J. P. Ferguson,Patrick Hole,Bob Carr,Christopher W.G. Redman,Adrian L. Harris,Peter J. Dobson,Paul Harrison,Ian L. Sargent +11 more
TL;DR: By combining NTA with fluorescence measurement it is demonstrated that vesicles can be labeled with specific antibody-conjugated quantum dots, allowing their phenotype to be determined, demonstrating that NTA is far more sensitive than conventional flow cytometry.
Journal ArticleDOI
Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.
TL;DR: Normal third-trimester pregnancy is characterized by remarkable activation of peripheral blood leukocytes, which is further increased in preeclampsia, and this activity is similar to those found in sepsis.
Journal ArticleDOI
Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Yuk-Ming Dennis Lo,N. M. Hjelm,Carrie Fidler,Ian L. Sargent,Michael F. Murphy,Paul Chamberlain,Priscilla M.K. Poon,Christopher W.G. Redman,J. S. Wainscoat +8 more
TL;DR: Noninvasive fetal RhD genotyping can be performed rapidly and reliably with the use of maternal plasma beginning in the second trimester of pregnancy.